Doctor profile · Federal record
Dr. JAMES OSTEEN, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · AMARILLO, TX
- NPI 1407234453
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 11 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1826 POINT WEST PKWY
AMARILLO, TX 791242167
(806) 358-8654
fax (806) 356-8687 - Mailing address
-
PO BOX 911230
DALLAS, TX 753911230
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- November 13, 2025
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Texas #R9413
- Medicaid
- TX #426605801
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407234453. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
242,954
Distinct HCPCS
10
Medicare allowed
$2,112,123
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 63,750 | 55 | $1 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 38,400 | 23 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 30,600 | 35 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,540 | 32 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 16,300 | 22 | $54 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 14,746 | 14 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,662 | 92 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 9,188 | 24 | $0 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 8,640 | 11 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,740 | 13 | $47 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 2,834. This provider delivers 86× the peer median.Open Payments
Industry payments received
All-time total
$220
Transactions
8
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $60.70 | |
| Abbott Laboratories | 1 | $47.65 | |
| Pharmacosmos Therapeutics Inc. | 2 | $42.59 | |
| Mirati Therapeutics, Inc. | 1 | $23.85 | |
| PFIZER INC. | 1 | $23.63 | |
| Genmab U.S., Inc. | 1 | $21.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
575
Patients
189
Total drug cost
$442,824
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 78 | 16 | $2,211 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 67 | 31 | $2,568 |
| Xarelto (Rivaroxaban) | Brand | 62 | 0 | $45,395 |
| Eliquis (Apixaban) | Brand | 57 | 16 | $40,119 |
| Prednisone | Generic | 46 | 14 | $212 |
| Fentanyl | Generic | 36 | 18 | $4,582 |
| Ondansetron Hcl | Generic | 36 | 27 | $376 |
| Dexamethasone | Generic | 29 | 17 | $418 |
| Acyclovir | Generic | 26 | 0 | $590 |
| Akynzeo (Netupitant/Palonosetron Hcl) | Brand | 26 | 0 | $19,240 |